Adimab

United States
Nashville, Michigan, United States
(603) 643-7110 ★

Company profile

Adimab company profile

Adimab's integrated antibody discovery and optimization platform provides unprecedented speed from antigen to purified, full-length human IgGs. Adimab offers fundamental advantages by delivering diverse panels of therapeutically relevant antibodies that meet the most aggressive standards for affinity, epitope coverage, species cross-reactivity and expressability. Adimab enables its partners to rapidly expand their biologics pipelines through a broad spectrum of technology access arrangements.

Business identity

Contact email
[email protected]
Phone number
(603) 643-7110
Operating status
Active
Company type
For Profit
Employee range
00101-00250 employees
Revenue range
$10K+
Founded
2007-05-01

Headquarters

Headquarters
Nashville, Michigan, United States
Postal code
03766
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
8
Total equity funding
$45.5M
Last funding
Series Unknown / 2020-01-01
Last equity funding
Series Unknown
Investors
6
Lead investors
3
Founders
3
Articles
137

Founders and investors

Founders

Errik AndersonK. Dane WittrupTillman Gerngross

Lead investors

Google VenturesPolaris PartnersSV Health Investors

Investors

Google VenturesLux CapitalOrbiMedPolaris PartnersSV Health Investors

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.